Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-01

Study Completion Date

2022-11-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test passive music therapy in patients receiving induction chemotherapy for an acute myeloblastic leukemia or undergoing an hematopoietic stem cell transplantation. The main questions it aims to answer are:

\- Can music therapy control physical and psychological symptoms and improve the mood and quality of life of these patients?

Participants will be randomly assigned to the control and experimental group. Patients included in both groups will complete weekly mood and quality of life questionnaires. Those included in the experimental group will also complete daily symptom burden questionnaires before and after listening to a music therapy session.

Researchers will confirm if the experimental group improves their symptoms after the music therapy session and will compare both groups to see if there are differences in mood and quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.

NCT03107273

Hematopoietic Cell Proliferation Myelodysplastic Syndromes

COMPLETED

A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT02975869

Acute Myeloid Leukemia

ACTIVE_NOT_RECRUITING NA

Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

NCT01245231

Leukemia

COMPLETED

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

NCT00049517

Leukemia

COMPLETED PHASE3

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myeloblastic Leukemia Hematopoietic Stem Cell Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled clinical trial

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AML-E

Acute myeloblastic leukemia - experimental

Group Type EXPERIMENTAL

Passive music therapy

Intervention Type BEHAVIORAL

Patients included in the experimental group receive a 25 min passive music therapy session on a daily basis, which changes depending on their emotion.

AML-C

Acute myeloblastic leukemia - control

Group Type NO_INTERVENTION

No interventions assigned to this group

AlloSCT-E

Allogeneic stem cell transplantation - experimental

Group Type EXPERIMENTAL

Passive music therapy

Intervention Type BEHAVIORAL

Patients included in the experimental group receive a 25 min passive music therapy session on a daily basis, which changes depending on their emotion.

AlloSCT-C

Allogeneic stem cell transplantation - control

Group Type NO_INTERVENTION

No interventions assigned to this group

AutoSCT-E(I)

Autologous stem cell transplantation - experimental (inpatient)

Group Type EXPERIMENTAL

Passive music therapy

Intervention Type BEHAVIORAL

Patients included in the experimental group receive a 25 min passive music therapy session on a daily basis, which changes depending on their emotion.

AutoSCT-C(I)

Autologous stem cell transplantation - control (inpatient)

Group Type NO_INTERVENTION

No interventions assigned to this group

AutoSCT-E(O)

Autologous stem cell transplantation - experimental (outpatient)

Group Type EXPERIMENTAL

Passive music therapy

Intervention Type BEHAVIORAL

Patients included in the experimental group receive a 25 min passive music therapy session on a daily basis, which changes depending on their emotion.

AutoSCT-C(O)

Autologous stem cell transplantation - control (outpatient)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Passive music therapy

Patients included in the experimental group receive a 25 min passive music therapy session on a daily basis, which changes depending on their emotion.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old.
* Patients receiving induction chemotherapy for a newly diagnosed acute myeloblastic leukemia (except for acute promyelocytic leukemia).
* Patients undergoing autologous or allogeneic stem cell transplantation.
* Being able to understand and read Spanish properly.
* Basic computer skills.